Cardiovascular-Research Only
Device
Abbott Laboratories
Total Payments
$13.5M
Transactions
1,907
Doctors
11
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $361,166 | 284 | 4 |
| 2018 | $13.2M | 1,623 | 10 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13.5M | 1,907 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | Abbott Laboratories | $11.4M | 0 |
| Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker | Abbott Laboratories | $609,022 | 0 |
| St. Jude Medical Product Longevity and Performance (SCORE) Registry | Abbott Laboratories | $524,570 | 6 |
| Quadripolar Pacing Post Approval Study | Abbott Laboratories | $306,399 | 5 |
| Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II) | Abbott Laboratories | $190,476 | 1 |
| AMPLATZER Duct Occluder II Additional Sizes (ADO II AS) Clinical Study | Abbott Laboratories | $174,532 | 0 |
| Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study (VPA) | Abbott Laboratories | $89,782 | 0 |
| CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients (ENHANCE CRT) | Abbott Laboratories | $80,631 | 0 |
| QuickFlex ? Model 1258T Left Heart Pacing Lead Post Approval Study | Abbott Laboratories | $33,268 | 0 |
| Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT) | Abbott Laboratories | $24,475 | 0 |
| 15mm Surgical Mechanical Mitral Valve IDE Study | Abbott Laboratories | $18,559 | 0 |
| Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder (ASO) Post Market Surveillance Study | Abbott Laboratories | $9,975 | 0 |
| Prospective, multicenter, post-market, single-arm, observational study | Abbott Laboratories | $6,294 | 0 |
| A Clinical Evaluation of the Safety of the St. Jude Medical Quartet 1457Q Left Ventricular Lead an Investigational Device Exemption (IDE) Study | Abbott Laboratories | $4,570 | 0 |
| PORTICO - Japan | Abbott Laboratories | $3,671 | 0 |
| Pilot Study Tailored Anticoagulation for Noncontinuous AF | Abbott Laboratories | $2,250 | 0 |
| ST Monitoring to Detect ACS Events in ICD Patients Study (Analyze ST) | Abbott Laboratories | $2,250 | 0 |
| Registry That Aims to Understand the Definition Used and Treatment Options Utilized by Clinicials for CRT Non-responders | Abbott Laboratories | $2,000 | 0 |
| CRT IMPLANT STRATEGY USING THE LONGEST ELECTRICAL DELAY FOR NON-LEFT BUNDLE BRANCH BLOCK PATIENTS (ENHANCE CRT) | Abbott Laboratories | $800.00 | 0 |
| ACCENT MRI PACEMAKER AND TENDRIL MRI LEAD IDE STUDY | Abbott Laboratories | $495.00 | 0 |
Top Doctors Receiving Payments for Cardiovascular-Research Only
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Winston-Salem, NC | $13.5M | 1,882 |
| , M.D | Interventional Cardiology | Springdale, AR | $4,850 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Burbank, CA | $4,035 | 3 |
| , MD | Cardiovascular Disease | Bryn Mawr, PA | $2,450 | 2 |
| , MD | Clinical Cardiac Electrophysiology | Sanford, FL | $2,275 | 5 |
| , M.D | Clinical Cardiac Electrophysiology | Los Angeles, CA | $915.00 | 2 |
| , M.D | Internal Medicine | Burlington, MA | $817.61 | 1 |
| , MD | Interventional Cardiology | Fresno, CA | $720.00 | 4 |
| , M.D | Cardiovascular Disease | Grand Rapids, MI | $500.00 | 1 |
| , MD | Cardiovascular Disease | Modesto, CA | $425.00 | 4 |
| , M.D | Clinical Cardiac Electrophysiology | Delray Beach, FL | $100.00 | 1 |
| , MD | Interventional Cardiology | Fresno, CA | $30.00 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $13.5M
Product Information
- Type Device
- Total Payments $13.5M
- Total Doctors 11
- Transactions 1,907
About Cardiovascular-Research Only
Cardiovascular-Research Only is a device associated with $13.5M in payments to 11 healthcare providers, recorded across 1,907 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2019. In 2019, $361,166 was paid across 284 transactions to 4 doctors.
The most common payment nature for Cardiovascular-Research Only is "Unspecified" ($13.5M, 100.0% of total).
Cardiovascular-Research Only is associated with 20 research studies, including "AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial" ($11.4M).